Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
American Strategic Investment Co. reported third quarter 2026 revenue of $7.1 million and a net loss of $6.7 million. The results reflect a decrease in revenue compared to the prior year due to the disposition of the 1140 Avenue of the Americas property. Subsequent to the quarter, the company signed a major lease extension and expansion with the State of New York at its 123 William Street property.
“The Company’s results this quarter build on the progress we made over the last two quarters, as our capital prioritization strategy continues to contribute to our results. The portfolio’s high quality, largely investment grade tenant base continues to support stable performance this year.”
Nicholas Schorsch, Jr., CEO of ASIC
“We remain focused on completing our remaining asset dispositions and directing capital toward the opportunities we believe will create the most durable value for our shareholders, such as the execution of the lease with the State of New York after the end of the quarter that increases pro-forma occupancy at 123 William Street to approximately 75% and portfolio occupancy to approximately 78%.”
Femasys reported financial results for the third quarter of 2026, highlighting a slight increase in U.S. sales to $0.35 million despite overall sales declining due to international distributor order timing. The company completed a $30 million private placement in August to fund the build-out of its U.S. commercial team and support the FemBloc pivotal trial.
Term
Q3 2026
“We maintained a lean team and tightly managed resources as we prioritized financing from long-term institutional investors. Closing the $30 million in financing in mid-August 2026 represents an important turning point for Femasys.”
Kathy Lee-Sepsick, Founder and Chief Executive Officer
“These results and commercial recruitment progress give us strong confidence that deploying our team in target U.S. territories will broaden adoption and drive revenue growth.”
Kathy Lee-Sepsick, Founder and Chief Executive Officer
For the nine months ended September 30, 2026, AB Private Credit Investors Corp reported net investment income after tax of $47.9 million, a significant increase from $42.3 million in the prior year period. However, net assets resulting from operations decreased to $24.2 million from $41.7 million year-over-year, primarily due to $22.3 million in net unrealized depreciation on investments.
NextPlat Corp reported third quarter 2026 financial results featuring a 35% improvement in gross profit and a 66% reduction in net loss. While consolidated revenue decreased to $10.5 million due to lower reimbursement rates, the company saw 300% growth in high-margin pharmacy contract revenue, specifically driven by 340B services.
Term
Q3 2026
“Our third quarter results reflect continued year-over-year improvement across the business, driven by the refocusing of our healthcare operations on high-value, high-margin services designed to deliver consistent bottom-line results in what remains a dynamic market.”
David Phipps, Chief Executive Officer and President of NextPlat Corp
“Our focus remains on growth and profitability through our differentiated, high-value healthcare services and expanding community pharmacy network, including our new Scott’s location near Pensacola and a new pharmacy in Jacksonville, supported by a more efficient operating structure.”
David Phipps, Chief Executive Officer and President of NextPlat Corp
Crescent Private Credit Income Corp reported total investment income of $62.2 million for the nine months ended September 30, 2026, a significant increase from $30.8 million in the prior year period. Net investment income rose to $33.2 million, though the company recorded net realized and unrealized losses on investments during the period.
Seritage Growth Properties continued its strategic plan to liquidate its real estate portfolio, focusing on asset dispositions to retire outstanding debt. The filing reflects a decrease in rental income as properties are sold, consistent with the company's transition toward dissolution.
Farmers & Merchants Bancshares, Inc. reported net income of $5.75 million for the nine months ended September 30, 2026, an increase from $4.07 million in the prior year period. The company saw a significant rise in net interest income to $20.7 million, driven by higher loan yields and a decrease in interest expense on deposits.
Biofrontera Inc. reported a net loss of $11.8 million for the nine months ended September 30, 2026, an improvement from the $16.2 million loss in the prior year period. Product revenues grew significantly to $31.2 million compared to $24.6 million in 2025, while the company's cash position decreased to $3.2 million as of the reporting date.
For the nine months ended September 30, 2026, KKR Infrastructure Conglomerate LLC reported a net increase in net assets resulting from operations of $558.0 million, driven by $589.2 million in unrealized appreciation on investments. Total assets grew to $9.22 billion from $6.59 billion at year-end 2025, reflecting significant capital deployment and investment performance.
Palomino Laboratories Inc. reported a net loss of $7.03 million for the nine months ended September 30, 2026, compared to a $2.42 million loss in the prior year, driven by a significant increase in R&D and G&A expenses. The company strengthened its balance sheet during the period, ending the quarter with $17.79 million in cash and cash equivalents.
AtlasClear Holdings reported a net loss of $1.05 million for the quarter ended September 30, 2026, compared to a loss of $0.44 million in the prior year period. While total revenues increased to $5.39 million driven by new stock locate fees, the company faced a delisting notice from NYSE American due to its low stock price and has transitioned trading to the OTC Pink Limited Market.
LFTD Partners Inc. reported a significant decrease in total assets from $19.27 million at year-end 2025 to $8.32 million as of September 30, 2026, primarily driven by a sharp reduction in inventory and accounts receivable. The company's total liabilities also decreased to $4.64 million, while management noted substantial doubt about the company's ability to continue as a going concern.
zSpace, Inc. reported a significant decrease in revenue to $14.2 million for the nine months ended September 30, 2026, compared to $23.0 million in the prior year. Despite the revenue decline, the net loss narrowed to $7.5 million from $18.1 million, aided by a $4.1 million gain on debt extinguishment and a $2.2 million gain from the change in fair value of preferred stock liabilities.
WTI Fund XI, Inc. reported a significant increase in total investment income to $13.7 million for the nine months ended September 30, 2026, compared to $6.7 million in the prior year period. Net assets grew to $37.9 million, driven by $20.6 million in shareholder contributions and a net increase in net assets from operations of $3.7 million, despite a $1.2 million unrealized loss on loans.
XMax Inc. reported a significant net income of $23.6 million for the nine months ended September 30, 2026, primarily driven by a $32.4 million unrealized gain on investments. This represents a substantial turnaround from a net loss of $1.8 million in the prior year period, despite a decrease in total revenue from $15.0 million to $10.9 million.
Eva Live Inc. reported a significant net loss of $65.2 million for the nine months ended September 30, 2026, primarily driven by a massive increase in general and administrative expenses including $58.3 million in stock-based compensation. Despite a slight decrease in total revenue to $11.8 million, the company significantly expanded its equity base through various share issuances for services and debt settlements.
Northwest Biotherapeutics reported a net loss of $41.1 million for the nine months ended September 30, 2026, an improvement from the $61.6 million loss in the prior year period. Total revenues increased to $2.2 million from $0.7 million, while operating expenses decreased significantly from $47.1 million to $34.6 million.
Air T, Inc. reported financial results for its second fiscal quarter ended September 30, 2026, with revenue increasing 129% to $146.9 million, primarily driven by the acquisition of Regional Express Holdings (Rex). The company reported a net loss of $7.48 per share, impacted by operational challenges at Rex including unscheduled engine removals and high fuel costs.
Term
Q2 2027
“While focused in one sector and with some interdependencies, Air T can be viewed as a set of businesses that operate independently of one another. The quarter just passed is an example of widely variable operational dynamics across our businesses.”
Nick Swenson, Company Chairman and CEO
“Rex financial performance was notably challenged in the quarter due to a combination of unscheduled engine removals, delays at engine overhaul shops and a doubling of fuel costs compared to pre-war levels.”
Calidi Biotherapeutics reported a net loss of $3.6 million for the third quarter of 2026, a significant improvement from the $10.8 million loss in the prior year period. The company highlighted preclinical progress for its CLD-401 program and implemented a restructuring plan on November 6, 2026, to reduce headcount and save $3 million annually. During the quarter, the company also raised $1.2 million through an at-the-market offering to extend its cash runway.
Term
Q3 2026
“Throughout the third quarter, Calidi continued to advance its RedTail platform for systemic and local delivery and redefine the potential of oncolytic viruses and genetic medicine. In particular, CLD-401 demonstrated remarkable anti-tumor activity with systemic administration in syngeneic tumor models and continues to progress towards the clinic.”
WTI Fund X, Inc. reported a net increase in net assets resulting from operations of $26.2 million for the nine months ended September 30, 2026, down slightly from $27.6 million in the prior year period. The company significantly reduced its debt facility borrowings from $232.5 million at year-end 2025 to $95.0 million, while net assets increased to $209.2 million.
ADM Endeavors, Inc. reported total revenue of $4.58 million for the nine months ended September 30, 2026, a slight increase from $4.31 million in the prior year period. The company achieved a net income of $127,075 for the first nine months of 2026, down from $250,321 in 2025, primarily due to significantly higher interest expenses and the absence of a large gain on an insurance claim seen in the previous year.
Forbright, Inc. filed its 10-Q for the period ending September 30, 2026, reporting 33,601,078 shares of Class A common stock outstanding. The filing highlights a pending branch sale agreement and the adoption of the 2026 Omnibus Incentive Plan, while emphasizing risks related to AI implementation and credit quality.
Churchill Capital Corp XI (CCXI) completed its business combination with Legacy Agility on November 2, 2026, subsequently changing its name to Agility Robotics, Inc. The filing covers the period ended September 30, 2026, prior to the merger's consummation, and reflects a pre-money equity value for Legacy Agility of $2.5 billion.
NexPoint Diversified Real Estate Trust reported total assets of $993.4 million as of September 30, 2026, a decrease from $1.07 billion at year-end 2025. The company experienced a significant increase in its accumulated loss to $458.2 million, while total shareholders' equity declined from $700.1 million to $610.6 million during the nine-month period.
Broadway Financial Corp reported net income of $1.1 million for the third quarter of 2026, a significant recovery from a $23.9 million loss in the prior year period which was driven by a $25.9 million goodwill impairment. Total assets grew to $1.56 billion as of September 30, 2026, primarily fueled by a $192.4 million increase in deposits and growth in the loan portfolio.
Air T Inc. reported a significant increase in operating revenues to $262.4 million for the six months ended September 30, 2026, driven by the addition of regional airline and aviation leasing segments. However, the company swung to a net loss of $35.2 million compared to a profit in the prior year, primarily due to higher operating expenses, increased interest costs, and a $3.4 million earnout remeasurement charge.
KPET Ultra Paceline Corp reported net income of $3.53 million for the nine months ended September 30, 2026, primarily driven by $4.08 million in interest earned on investments held in the Trust Account. As a shell company, its primary assets consist of $233.8 million in the Trust Account, while it maintains a shareholders' deficit of $11.23 million due to the accretion of Class A ordinary shares to redemption value.
Golden Minerals Company reported a net loss of $0.7 million for the nine months ended September 30, 2026, an improvement from a $3.0 million loss in the prior year period, primarily due to $1.1 million in income from discontinued operations. The company remains in the exploration stage with no mineral reserves, maintaining a cash balance of $1.7 million as of the end of the third quarter.
Moleculin Biotech reported a net loss of $27.0 million for the nine months ended September 30, 2026, compared to a $49.1 million loss in the prior year period. The company ended the quarter with $7.3 million in cash and cash equivalents, supported by $20.3 million in net cash provided by financing activities during the year.
For the nine months ended September 30, 2026, Silo Pharma reported a net loss of $2.84 million, an improvement from the $3.35 million loss in the prior year period. The company's cash position increased to $6.09 million, bolstered by a $0.70 million gain from the termination of a sublicense agreement and financing activities.